InvestorsHub Logo
Followers 831
Posts 120032
Boards Moderated 17
Alias Born 09/05/2002

Re: DewDiligence post# 1947

Friday, 07/30/2021 9:30:42 AM

Friday, July 30, 2021 9:30:42 AM

Post# of 3016
ABBV 2Q21 Mavyret sales=$441M, +6% QoQ:

https://news.abbvie.com/news/press-releases/abbvie-reports-second-quarter-2021-financial-results.htm

New-patient starts are increasing but are not (yet) back to pre-pandemic levels.

ABBV’s full-year 2021 Mavyret guidance is $1.9B, down from the prior guidance of $2.0B.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ENTA News